ILADS Campaign Highlights Importance of Doctor-Patient Relationship in Treating Chronic Diseases
CHEVY CHASE, Md., Dec. 23, 2021 (GLOBE NEWSWIRE) -- The International Lyme and Associated Diseases Society (ILADS) is running a...
Year: 2021
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
TOKYO, Japan and CAMBRIDGE, United Kingdom, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“Sosei Heptares”; TSE: 4565) today...
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
LOWELL, Mass., Dec. 23, 2021 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
Core One Labs Acquires New Path Laboratories
VANCOUVER, British Columbia, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
Vaxxinity Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
DALLAS, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new...
Aeterna Zentaris Appoints Giuliano La Fratta as Chief Financial Officer
– Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and professional services sectors TORONTO, ONTARIO,...
NeuBase Therapeutics Reports Business Update and Financial Results for Fiscal Year 2021
Validated ability to Drug the Genome™ to address both rare and common diseases without the limitations of early precision genetic...
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Dec. 23, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Marizyme Announces the Closing of My Health Logic Acquisition Along With Initial Financing
JUPITER, Fla., Dec. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Marizyme Inc. (“Marizyme” or the “Company”) (OTCQB:MRZM), is pleased...
TREBOR RX CORP. CAREGuard+™ with ZENGuard™ technology has best in class, Viral Filtration Efficiency of 99.99%+
COLLINGWOOD, Ontario, Dec. 23, 2021 (GLOBE NEWSWIRE) -- As the FIFTH -- and potentially subsequent -- waves of COVID/OMICRON hit...
EssilorLuxottica : EssilorLuxottica and GrandVision enter into an agreement with ORIG BENE, a member of MPG Austria, for the sale of stores in the Netherlands and Belgium
EssilorLuxottica and GrandVision enter into an agreementwith ORIG BENE, a member of MPG Austria, for the saleof stores in the...
Disclosure of received notification of The Capital Group Companies
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 December 2021 – 7:00 PM CET Disclosure of received notification of The Capital Group...
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
VLN® Cigarettes VLN® King & VLN® Menthol King VLN® Is World’s First and Only Combustible Cigarette to Receive FDA MRTP...
Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site
Saint Herblain (France), December 23, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced...
CENTR Brands Corp. Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 24, 2021) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company") is...
CVR Medical Corp. Announces Closing of Capital Raise
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2021) - CVR Medical Corp. (TSXV: CVM) (OTC Pink: CRRVF) ("CVR Medical" or...
Empatho Holdings Inc. Receives Final Approval for Listing and Announces Start of Trading on the Canadian Securities Exchange
Toronto, Ontario--(Newsfile Corp. - December 23, 2021) - Empatho Holdings Inc. (formerly, Shane Resources Ltd.) (the "Company") is pleased to...
Cannabis Suisse Corp. Reports Year Results for 2021
DIETIKON, SWITZERLAND / ACCESSWIRE / December 23, 2021 / Cannabis Suisse Corp. (OTC PINK:CSUI), registered in the state of Nevada,...
Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this...
Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam in Alzheimer’s Disease
New website (www.Rethink-ALZ.com) is intended to increase visibility and information for potential study participants.Rethink-ALZ.com connects patients with nearest participating clinical...